Advanced Research and Invention Agency Bill

Nigel Evans Excerpts

2nd reading
Tuesday 23rd March 2021 Commons Chamber

[Carol Monaghan (Glasgow North West) (SNP) [V]]

Most Members understand the importance of proper science funding, both in terms of supporting research excellence and as an economic multiplier, and I certainly welcome any announcement of additional funding. However, in a week when we have seen UK Research and Innovation funding for official development assistance being cut, and when we are facing ongoing uncertainty regarding our association fee for Horizon Europe, we have to be sceptical about whether this agency will really attract new funding, or whether this will simply involve the re-profiling of existing funds.

In his evidence on ARIA to the Science and Technology Committee last week, Dominic Cummings referenced the Manhattan project, Turing’s work on the Enigma code and the development of computers as projects that would have benefited from funding free from bureaucratic constraints. All those projects had one thing in common: a specific target. We need to have some idea of what ARIA’s mission should actually be. What are its priorities? Net zero technology? Autonomous vehicles? Quantum computing? I do not think any of us would deny that, if the UK were to face a specific urgent challenge, there would be a need to get money where it was needed, and fast. The difficulty here is that we are being asked to support a Bill to set up a body to fund high-risk research, but we do not know what we will be researching or why. In last week’s evidence session, Dominic Cummings talked extensively about the bureaucracy of current funding, and stated this as one of the reasons for the new body. We have heard from researchers about the difficulties in applying for funding, but we would surely be better off tackling that, rather than creating a new agency when we do not have a mission.

Earlier, the Chair of the Select Committee, the right hon. Member for Tunbridge Wells (Greg Clark), talked about the importance of failure. It is frustrating that we do not recognise how key failure is to scientific development. Failure is information. It tells us that something does not work, and science research often has many instances of failure before we experience success. This speaks to how we measure success in science through papers looking for positive outcomes. Maybe we should be looking more at papers that talk about negative outcomes or nor outcomes at all, because that is information too.

In everything, there must be accountability. Government spending during the pandemic on flawed procurement contracts should have taught us that there must be checks and balances in public money to ensure that cronyism is not the overriding decision maker. Removing ARIA from any freedom of information requests is problematic and will certainly leave it open to such cronyism. I would like some clarification on how extreme freedom in research does not mean extreme recklessness and cronyism in spending.



I would also like to raise the issue of national inequality of research spending. The recent National Audit Office report on the industrial strategy challenge fund noted:

“The Fund is unevenly spread across the UK with the majority being provided to the West Midlands, South East and London”.

This is not a new situation. For decades, we have seen capital spending on research concentrated on the south-east of England. I would therefore like to hear something about how the Government will ensure that ARIA is fully representative of the devolved nations.

The Government promised to double R&D spending to £22 billion by 2024 and repeatedly talk of being a science superpower. However, we are yet to see full details on this spending. The Business Secretary has admitted that UKRI’s 2021-22 budget has not yet been agreed, so a long-term funding plan for science should have some certainty for the funding cycles that we are already in.

The UK’s status as a science superpower is underpinned by international research collaboration and we need to make sure that that is protected. It is concerning that UKRI has announced a shortfall of £120 million between its official development assistance allocation and its commitment to grant holders. I have asked repeatedly about our commitment on Horizon Europe contributions, and, in the last few weeks, there has been no further information. We need to know whether the contributions will come from new money or whether UKRI will see its budget further squeezed to pay our association fee. Although many of us support an additional £800 million for science research, it really is difficult for us to work out whether it is actually new money. We need to see the sums and we need that clarity.

Finally, I pay tribute to my hon. Friend the Member for Airdrie and Shotts (Neil Gray). He is a well-respected and much liked colleague across the House. I know personally how hard he works and that he gives 100% both to his parliamentary duties and to his family. I hope that he has great success in his new endeavours and that he has the opportunity to spend more time with his family, because all of us with families who have to travel to this place know that it can be a huge strain. All the best, Neil, and take care.

[Mr Deputy Speaker (Mr Nigel Evans)]

I would like to add my good wishes as well, as this is my first time in the Chair today. Good luck, Neil.

--- Later in debate ---

[Jim Shannon (Strangford) (DUP)]

It is a pleasure to speak in this debate. First, I congratulate the hon. Member for Airdrie and Shotts (Neil Gray) and wish him all the best as he leaves this place. I always find him a very easy fella to get on with. We have worked together in many debates; usually I intervened on him, and maybe there was the odd time when he intervened on me. We have a good friendship, and I wish him and his family well. We will miss his friendship in the Chamber.

I am a strong supporter of Government’s aim to increase public research and development funding to £22 billion by 2024-25 and to increase overall UK spending on R&D to 2.4% of GDP by 2027. I welcome and am really pleased to see the Government’s proposals. I will not make a plea for my own constituency, but I will make a plea for Northern Ireland as an area where we believe that we can help each other.

If we ever needed proof or a supreme example of just how well we can do things—when I say “we”, I mean the United Kingdom of Great Britain and Northern Ireland; all of us better together under the Union flag, which is where the strength of our co-operation and friendship should be—who could fail to be amazed by the development of the vaccine? From the start to the end, we have got a number of effective vaccines on the streets within a year. After all the difficulties of the last year, the success story has been the vaccine and its roll-out. Which of us did not feel a wee bit better when the vaccines were announced by the Health Secretary in the Chamber? We could almost feel a smile on our face and a skip in our step. That was because of the scientists and the expertise that we have in this great United Kingdom of Great Britain and Northern Ireland, leading the way. That is why I believe that the science and the R&D can and, indeed, will succeed.

I can understand those who are concerned at the speed of the vaccine development—they know that R&D usually takes years, but the coronavirus is an example of where it can take less time. The difference that dedicated funding and governmental support makes is clear. The Government and the Prime Minister in particular initially made sure that money was set aside for the research. Clearly that was a good move, and we thank them for it. The money is there to roll out the programmes, hire the staff and purchase the necessary equipment, and we have vaccines available because we invested; our Government and our country—our great United Kingdom of Great Britain and Northern Ireland—invested.

Imagine what we could achieve if we put resources into other goals—if we thought big and funded those thoughts. Is it wrong to aim for the stars? I do not think it is. In the last year, we have aimed for the stars and achieved it. The right hon. Member for Kingswood (Chris Skidmore) referred to the moonshot goals. One of my favourite films is “It’s a Wonderful Life”. We all know the scene where James Stewart’s character talks about lassoing the moon, and it is not impossible to do some things we have always talked about doing in a romantic way. We can do great things in research and development through the moonshot goals.

Of course there must be regulation and restrictions. Common sense should go hand in hand with idealism, and we must ensure that safety is paramount. If we look at what we have done, it shows the best of British and the best of what we can achieve, with co-operation between Scotland, Wales, Northern Ireland and the mainland, as well as with our international colleagues; what a sight that is to behold. The Bill applies to the whole United Kingdom of Great Britain and Northern Ireland. Supporting scientific research and development sits within the legislative competence of the devolved nations—in my case, the Northern Ireland Assembly—although specific reservations exist, and I look forward to the devolved nations contributing to this process and passing their consent.

In a debate in Westminster Hall last week, at which the Under-Secretary of State for Business, Energy and Industrial Strategy, the hon. Member for Derby North (Amanda Solloway), was present, I mentioned Queen’s University Belfast and the great partnerships that it has in health research in particular to find cures for diseases such as cancer and diabetes. Every now and again, that research has dividends and they are able to announce some of the good things they have done. Again, I ask the Minister to ensure that we can all benefit from the partnerships with universities and companies. As others have said, universities across the whole of the United Kingdom can deliver opportunities for people to progress their degrees, carry out investigations and find cures.

Northern Ireland has an excellent workforce—highly skilled, young, capable and educated to the standard that we all want. To give just one example, cyber-security in Northern Ireland is the best in the United Kingdom—indeed, the best in Europe. I suggest to the House that our workforce, their skills and their capability be used as we all move forward together.

My one note of caution is that while we must be ambitious, we must also be realistic. There cannot be a blank cheque for any project, but I believe that clause 3, on long-term ambition, must have a common-sense element and that projects must have an end date. We must be aware of our finite budget and of the need to fund projects that can provide immediate results and benefits such as pancreatic cancer drugs. I am my party’s health spokesperson, so I am very interested in how we can work together to find cures for diseases and reduce the number of deaths they cause across the whole of the United Kingdom. I look forward the fund being made available for health projects, as well as technological advances.

I support our research and development, I support the Bill and I support this Government and the Minister in the work she does. The Bill gives us a vision of the future—a vision that we must grasp. We have a glimpse of what we can achieve, and the potential can and must be exploited in a reasonable way for everyone in the United Kingdom of Great Britain and Northern Ireland, always better together.

[Mr Deputy Speaker (Mr Nigel Evans)]

Before I call the next speaker, I point out that everyone remaining to speak in this debate is from one political party, so if you go wildly over the five-minute mark, you may be pushing one of your colleagues off the list. There is a challenge for Ian Liddell-Grainger.

Advanced Research and Invention Agency Bill

Nigel Evans Excerpts

Report stage & 3rd reading
Monday 7th June 2021 Commons Chamber

[Stephen Flynn (Aberdeen South) (SNP)]

I beg to move, That the clause be read a Second time.

[Mr Deputy Speaker (Mr Nigel Evans)]

With this, it will be convenient to discuss the following:

New clause 2—ARIA’s primary mission: health research and development—

“(1) The primary mission of ARIA is to support scientific research into human health and the development of new medicines and health technologies.

(2) In carrying out its primary mission under subsection (1), ARIA must prioritise research and development according to the policy objectives of the Department of Health and Social Care.”

This new clause would set ARIA’s primary mission as supporting health research and development and would make the Department of Health and Social Care the Agency’s main client.

New clause 3—Transition to net-zero carbon emissions—

“(1) ARIA must be certified carbon-neutral at the end of each financial year.

(2) 25% of ARIA’s annual budget must be directed towards scientific research and development that will support the UK’s transition to net zero carbon emissions by 2045.

(3) In exercising any of its functions under this Act, ARIA must have regard to the requirement under subsection (1) and the UK’s transition to NetZero carbon emissions by 2045.”

This new clause requires ARIA to be certified carbon-neutral annually, and to direct 25% of its annual budget to research and development that will assist the UK’s transition to net-zero. In carrying out its functions, ARIA must have regard to its carbon-neutrality requirement and the UK’s transition to net-zero.

Amendment 1, in clause 2, page 1, line 7, at end insert—

“(A1) ARIA’s primary mission will be to support the development of technologies and research that support the UK’s transition to net zero carbon emissions or reduce the harmful effects of climate change.”

This amendment sets the primary mission for ARIA to support the development of technologies and research that support the UK’s transition to net zero carbon emissions or reduce the harmful effects of climate change.

Amendment 2, page 1, line 17, at end insert—

“(2A) Where ARIA provides financial support or makes rights or other property available under subsection (2) to an individual who has a family or business connection to a Minister of HM Government—

(a) that individual must make a declaration of the connection as part of the application for support or property; and

(b) the Minister must make an oral statement to the House of Commons within 3 months of the decision being made under subsection (2).”

This amendment would allow for Parliamentary scrutiny of any contracts awarded by ARIA to a person connected to a member of the Government.

Amendment 12, page 1, line 17, at end insert—

“(2A) In exercising its functions, ARIA must have regard to its core mission.

(2B) In this section “core mission” means—

(a) for the period of ten years after the date on which this Act is passed, undertaking activities which support the achievement of the target established in section 1 of the Climate Change Act 2008,

(b) thereafter, mission or missions which the Secretary of State establishes by regulations every five years, and

(c) regulations under this section—

(i) shall be made by statutory instrument, and

(ii) may not be made unless a draft has been laid before and approved by resolution of each House of Parliament.”

This amendment would require ARIA to consider its core mission in exercising its functions. For the ten years following the Act passing, that core mission would be supporting the achievement of Net Zero. Thereafter, its mission will be established by statutory instrument subject to the draft affirmative procedure.

Amendment 13, page 2, line 18, at end insert—

“(7) In exercising its functions, ARIA must have regard to its impact across England, Scotland, Wales and Northern Ireland and each region thereof.

(8) The annual report prepared under paragraph 15 of Schedule 1 must contain—

(a) the geographical distribution of ARIA’s investments over the past year, and

(b) the economic impact of this investment in each region and nation of the United Kingdom including the number of new jobs created.”

This amendment would require ARIA to have regard for the benefits of its activities across the nations and regions of the UK in exercising its functions and includes a reporting function, with Parliamentary oversight, on the impact of those activities in each nation and region of the UK.

Amendment 4, in clause 4, page 2, line 25, at beginning insert—

“Subject to paragraph 3(1B) of Schedule 1,”

This amendment is consequential to Amendment 3.

Amendment 6, page 2, line 25, at beginning insert—

“Subject to paragraph 2(3B) of Schedule 1,”

This amendment is consequential to Amendment 5.

Amendment 9, in clause 6, page 3, line 2, at end insert—

“(2A) ARIA must provide the House of Commons Science and Technology Committee with such information as the Committee may request.”

This amendment would require ARIA to share information with the House of Commons Science and Technology Committee when requested.

Amendment 14, on page 3, line 15, at end insert—

“(7) ARIA shall be—

(a) a public authority within the meaning of section 3 of the Freedom of Information Act 2000, and Schedule 1 of that Act shall be amended accordingly, and

(b) a central government authority within the meaning of regulation 2(1) of the Public Contracts Regulations 2015, and Schedule 1 of those Regulations shall be amended accordingly.”

This amendment would make ARIA subject to the Freedom of Information Act 2000 and the Public Contract Regulations 2015.

Amendment 10, in clause 8, page 3, line 26, leave out “, and” and insert—

“(ab) the House of Commons Science and Technology Committee, and”

This amendment would require the Secretary of State to consult the House of Commons Science and Technology Committee before dissolving ARIA.

Amendment 5, in schedule 1, page 6, line 22, at end insert—

“(3A) The Secretary of State may not appoint a person as chair unless the appointment of that person has been approved by resolution of each House of Parliament.

(3B) ARIA may not exercise any functions under this or any other Act, nor may the Secretary of State make any grants to ARIA under section 4 of this Act, until its first chair has been appointed.”

This amendment requires both Houses of Parliament, under the affirmative resolution procedure, to approve the name of the proposed Chair. ARIA may not exercise any functions, nor may the Secretary of State make any grants to ARIA until its first chair has been appointed.

Amendment 3, page 6, line 26, at end insert—

“(1A) The Secretary of State may not appoint a person as Chief Executive Officer unless the appointment of the person has been approved by resolution of each House of Parliament.

(1B) ARIA may not exercise any functions under this or any other Act, nor may the Secretary of State make any grants to ARIA under section 4 of this Act, until its first Chief Executive Officer has been appointed.”

This amendment requires both Houses of Parliament, under the affirmative resolution procedure, to approve the name of the proposed Chief Executive Officer. ARIA may not exercise any functions, nor may the Secretary of State make any grants to ARIA until its first Chief Executive Officer has been appointed.

Amendment 11, page 7, line 1, at end insert—

“(6) The Secretary of State may not make executive or non-executive appointments to ARIA, nor determine the renumeration of appointees, without approval by resolution of the House of Commons Science and Technology Committee.”

This amendment would require the House of Commons Science and Technology Committee to approve the Secretary of State’s nominated executive and non-executive members, as well as their remuneration.

Amendment 7, in schedule 3, page 13, leave out paragraph 11.

This amendment would remove ARIA’s exemption from the Public Contracts Regulations 2015.

Amendment 8, on page 14, at end insert—

“(12) In Part VI of Schedule 1 to the Freedom of Information Act 2000 (“Other public bodies and offices: general”), at the appropriate place insert ‘The Advanced Research and Invention Agency’.”

This amendment would make ARIA subject to the Freedom of Information Act 2000.

Before I call Stephen Flynn, I must point out that there has been quite a significant number of withdrawals from this debate, for obvious reasons. Should anyone else wish to withdraw, will they please do so through the Speaker’s Office so that we can be notified? Also, anybody who is working off the call list and thinks that they are, say, five off, will need to think again. Anyone intending to participate in the debate physically really should make their way to the Chamber.

--- Later in debate ---

[Stephen Flynn]

I thank the hon. Member for his intervention, but we will have to heartedly disagree on this point. The House, and we as democratically elected representatives, should seek to play as key and active a role as possible. Of course, all this could be avoided by the Government simply agreeing on what ARIA’s mission should be in the first place.

Our new clause 1, on human rights, would ensure that ARIA’s record in that regard is of the highest standing. I certainly hope Members across the Chamber would agree to that. If they did not, I would be somewhat concerned. We saw that in Committee, which took me a bit by surprise, but perhaps some of the Government’s Back Benchers were not galvanised enough to encourage the Government to take a different stand. The SNP tabled the new clause because ultimately we do not know where ARIA will seek to put its investments. We do not know what it will seek to invest in, where it may even take a share in an organisation. It will have the freedom to do that, but that freedom means it may delve into areas we find unsuitable in relation to human rights. That is particularly pertinent when we look at the situation in China with the Uyghurs. I encourage Members on the Government Benches to take cognisance of that fact this evening.

Finally, it would be remiss of me not to mention the role of Scotland in relation to the Bill, because I very much like talking about that. The reality is that, where the Government are seeking to spend money, that Government money should be spent fairly and evenly across the United Kingdom—that is, while we still remain a part of the United Kingdom. To that end, there should be a Barnett share of money spent on Scotland. Where that money is spent, it should not seek to bypass devolution, as the Government seek to do in a number of areas, from the shared prosperity fund to the levelling-up fund and the United Kingdom Internal Market Act 2020. Scotland should have its fair share.

[Mr Deputy Speaker (Mr Nigel Evans)]

May I reiterate again that anybody who wishes to withdraw from the debate—we have had 35 people withdraw already—should please do so through the Speaker’s Office? If you are on the call list, please do not assume that the people above you have not withdrawn. The chances are that they have.

[Mrs Theresa May (Maidenhead) (Con)]

Mr Deputy Speaker, I am not sure whether your reiteration just before I stood up to speak, that you hope that anybody who wants to withdraw will do so, was a hint. When I put in to speak in the debate, I had intended to speak on a new clause that has not been selected, but after looking at the other amendments and new clauses, there is one aspect that I want to speak on briefly.

I apologise to those Members of the House who were on the Committee, because I can see that there was quite an exchange on these matters in Committee, but I want to pick up on an issue that was raised by the hon. Member for Aberdeen South (Stephen Flynn), who talked about the need for a mission and, in a sense, to restrict this organisation’s mission. He spoke particularly about climate change, which I know is a key issue. I was the Prime Minister who put the 2050 net zero emissions target into legislation, and the UK can be very proud of having been the first major country to do that.

An enormous amount of work needs to be done to ensure that we can take the decisions individually, as businesses and as a Government that will lead to net zero. Part of that will be about research, but as my hon. Friend the Member for North East Bedfordshire (Richard Fuller) said, there are enormous numbers of people out there doing research and companies looking for products to sell that will help to get us to that position. It seems to me that we should not restrict the mission of ARIA. It is important to give this organisation the freedom to look widely. I say that not just in a blue skies thinking way, but also because I had some interaction with the American equivalent of ARIA, on which ARIA is based, when I was Home Secretary because it was doing some really interesting research and innovative work on issues of security.

In evidence to the Committee, Professor Bond suggested that ARIA should be about

“radical innovation, which is different from grand missions and grand challenges.”––[Official Report, Advanced Research and Invention Agency Public Bill Committee, 14 April 2021; c. 20, Q16.]

That reference to “grand challenges” was, I am sure, a reference to the modern industrial strategy, sadly now cast aside, which set out grand challenges but also set out the aim for the UK to be the most innovative economy, and ARIA can have a real impact in that area.

The challenge for ARIA is that it needs to be truly innovative, it needs to have blue skies thinking and it needs to be doing what other people are not doing, but it has to have a purpose in doing that. What I hope we will not see is an organisation where lots of scientists and people get together, think lots of wild thoughts, enjoy talking about them and possibly publish a few papers, but at the end of the day, there is no practical difference to people’s lives as a result of that. The aim of this is to do that innovative thinking but, in due course, for that innovative thinking—whether it is taken up by other scientists, business or whoever—to lead to a real improvement in people’s lives.